Lupus Trial, Recruiting NCT03138941 Sponsor: Monash University Condition: Lupus
Back to Lupus

Lupus Trial, Recruiting

NCT03138941
Recruiting Not Applicable 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Systemic Lupus Erythematosus (lupus/SLE), confirmed by meeting specific medical classification standards — either at least 4 out of 11 criteria from a 1997 checklist, or at least 4 out of 17 criteria from a 2012 checklist (with certain combinations required), or a form of lupus affecting the kidneys alongside specific test results (confirm with trial site for details on which criteria apply).
  • People who are newly diagnosed with lupus, as well as those who have had the condition for a long time.
  • People who are 18 years of age or older.
  • People who are able to understand and sign a written consent form.

Who may not be able to join:

  • People who are under 18 years of age.
  • People who are unable to provide their own written consent to participate.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Eric Morand, Monash University

Phone: + 61 3 8572 2650

Australian sites

Rheumatology Unit, Royal Adelaide Hospital, Adelaide, South Australia
Department of Rheumatology, Flinders Medical Centre, Adelaide, South Australia
School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing & Health Sciences, Clayton, Victoria
Department of Rheumatology, St Vincent's Hospital (Melbourne), Fitzroy, Victoria

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Monash University
Registry
ClinicalTrials.gov
Start date
1 September 2013
Est. completion
31 December 2027

Where this trial is recruiting

🇦🇺 Australia 🇨🇳 China Hong Kong 🇮🇩 Indonesia 🇯🇵 Japan 🇵🇭 Philippines 🇸🇬 Singapore 🇰🇷 South Korea Sri Lanka 🇹🇼 Taiwan 🇹🇭 Thailand

4 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

SLICC-ACR Damage Index

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov